Robert E. Landry
2020
In 2020, Robert E. Landry earned a total compensation of $6.2M as Executive Vice President, Finance and Chief Financial Officer at Regeneron Pharmaceuticals, a 22% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $938,872 |
|---|---|
| Option Awards | $3,459,499 |
| Salary | $825,577 |
| Stock Awards | $949,560 |
| Other | $24,195 |
| Total | $6,197,703 |
Landry received $3.5M in option awards, accounting for 56% of the total pay in 2020.
Landry also received $938.9K in non-equity incentive plan, $825.6K in salary, $949.6K in stock awards and $24.2K in other compensation.
Rankings
In 2020, Robert E. Landry's compensation ranked 1,665th out of 13,090 executives tracked by ExecPay. In other words, Landry earned more than 87.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,665 out of 13,090 | 87th |
Division Manufacturing | 631 out of 5,617 | 89th |
Major group Chemicals And Allied Products | 229 out of 2,248 | 90th |
Industry group Drugs | 192 out of 1,948 | 90th |
Industry Pharmaceutical Preparations | 133 out of 1,453 | 91st |
Source: SEC filing on April 23, 2021.
Landry's colleagues
We found four more compensation records of executives who worked with Robert E. Landry at Regeneron Pharmaceuticals in 2020.
2020
Leonard Schleifer
Regeneron Pharmaceuticals
Chief Executive Officer
2020
George Yancopoulos
Regeneron Pharmaceuticals
Chief Scientific Officer
2020
Andrew Murphy
Regeneron Pharmaceuticals
Executive Vice President, Research
2020
Daniel Van Plew
Regeneron Pharmaceuticals
Executive Vice President and General Manager, Industrial Operations and Product Supply
News
Regeneron Pharmaceuticals Executive Vice President and General Manager, Industrial Operations and Product Supply Daniel Van Plew's 2021 pay rises 1% to $8.8M
April 21, 2022
Regeneron Pharmaceuticals CEO Leonard Schleifer's 2020 pay jumps 531% to $135M
April 23, 2021
Regeneron Pharmaceuticals CEO Leonard Schleifer's 2019 pay slips 19% to $21M
April 24, 2020
Regeneron Pharmaceuticals CEO Leonard Schleifer's 2018 pay stays at $27M
April 26, 2019